Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 2,242 shares at $12.09 ($27K) on 2025-03-17, disclosed to the SEC on 2025-03-19.
Scheduled sale ($27k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.09 | 2,000 | $24K | 90.7% |
| 2 | $10.24 | 242 | $2K | 9.3% |
| Total | $11.89 avg | 2,242 | $27K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |